HALLAM THOMAS (Chief Executive Officer) purchased 227.4% of their position (40K shares) of PALISADE BIO, INC. on the open market
Open‑market purchase worth $10.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/18/2022ACC: 0001493152-22-023511
DirectorOfficer· Chief Executive Officer
Since Apr 2021
+120K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
120K acquired
Non-Derivative Transactions1
Common Stock, par value $0.01
Direct
Shares
+40K
Price / share
$0.25
Trade value
$10K
% of position
227.4%
8/16/2022
17.59K→57.59K
Total
Net shares
+40K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 Direct | 8/16/2022 | P · Purchase | +40K | $0.25 | $10K | 227.4% | 17.59K | 57.59K |
| Total | +40K | $10K | ||||||
Derivative Transactions2
Series 1 Common Stock Purchase Warrant
Direct
Converts to
Common Stock
40K shares
Shares
+40K
Strike price
0.25
Held after
40K
Exercisable
—
8/16/2022
Series 2 Common Stock Purchase Warrant
Direct
Converts to
Common Stock
40K shares
Shares
+40K
Strike price
0.25
Held after
40K
Exercisable
—
8/16/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series 1 Common Stock Purchase Warrant Direct | Common Stock40K shares | 8/16/2022 | P · Purchase | +40K | 0.25 | — | 40K |
| Series 2 Common Stock Purchase Warrant Direct | Common Stock40K shares | 8/16/2022 | P · Purchase | +40K | 0.25 | — | 40K |